InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Koconis John, Chairman & CEO. Director active across 1 companies, notably Timber Pharmaceuticals, Inc.. Cumulatively, 2 filings have been recorded. Total volume traded: €14k. The latest transaction was filed on 15 December 2021 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations2 total
€6,82520,000 shares@ €0.3413100.0% of flow
Common Stock, par value $0.001 per share
SEC:0001104659-21-150535·
Ideal exit: 11 Sept 2022 (T+270)
€6,82520,000 shares@ €0.341350.0% of flow
Common Stock, par value $0.001 per share
SEC:0001104659-21-150535:0·
Ideal exit: 11 Sept 2022 (T+270)
2 of 2 declarations
About Koconis John
John Koconis is the CEO & President of Timber Pharmaceuticals, Inc. In this role, he is responsible for the strategic direction and management of the company's operations. John is committed to promoting innovation and efficiency, ensuring that Timber Pharmaceuticals meets its financial objectives. His experience in the pharmaceutical sector is a major asset for the company.
